N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2
H Wang, B Xu, J Shi - Gene, 2020 - Elsevier
Abstract N6-methyladenosine (m6A) is the most prevalent internal modification in
mammalian mRNAs and methyltransferase-like 3 (METTL3) is a vital methyltransferase in …
mammalian mRNAs and methyltransferase-like 3 (METTL3) is a vital methyltransferase in …
Screening for occult cancer in patients with venous thromboembolism: past, present, and future
A strong link between cancer and thrombosis has been well recognized. The occurrence of
venous thromboembolism (VTE) can be the first clinical sign of an undiagnosed (ie, occult) …
venous thromboembolism (VTE) can be the first clinical sign of an undiagnosed (ie, occult) …
ERS International Congress 2021: highlights from the pulmonary vascular diseases assembly
M Lichtblau, L Piccari, S Ramjug, A Bokan… - ERJ open …, 2022 - Eur Respiratory Soc
This article aims to summarise the latest research presented at the virtual 2021 European
Respiratory Society (ERS) International Congress in the field of pulmonary vascular disease …
Respiratory Society (ERS) International Congress in the field of pulmonary vascular disease …
[HTML][HTML] Transcription factor KLF16 activates MAGT1 to regulate the tumorigenesis and progression of breast cancer
L Li, X Zhang, Y Li, B Xiao, S Pei… - International …, 2022 - spandidos-publications.com
Breast cancer is the most frequent cause of cancer‑related mortality among women
worldwide. The present study aimed to explore the role of magnesium transporter protein 1 …
worldwide. The present study aimed to explore the role of magnesium transporter protein 1 …
Thromboembolism in muscle-invasive bladder cancer. a population-based nationwide study
S Jahnson, T Gårdmark, A Hosseini… - Bladder …, 2021 - content.iospress.com
Thromboembolism in Muscle-Invasive Bladder Cancer. A Population-based Nationwide Study
- IOS Press You are viewing a javascript disabled version of the site. Please enable Javascript …
- IOS Press You are viewing a javascript disabled version of the site. Please enable Javascript …
Diferenças de apresentação e manejo de pacientes com câncer e diagnóstico de tromboembolismo venoso (TEV) em um hospital privado em Salvador/Bahia …
JAC VIEIRA - 2021 - repositorio.bahiana.edu.br
Introdução: O câncer é um fator de risco para o desenvolvimento de trombose venosa
profunda (TVP) e tromboembolismo pulmonar (TEP). Dessa forma, pacientes que …
profunda (TVP) e tromboembolismo pulmonar (TEP). Dessa forma, pacientes que …
Predictors of long-term cancer diagnosis after an unprovoked thromboembolic event: A post-hoc analysis of the REVERSE cohort study
Results Between October 2001 and March 2006, 663 patients were enrolled and completed
the follow-up period. Among 663 patients presenting with unprovoked VTE and completing a …
the follow-up period. Among 663 patients presenting with unprovoked VTE and completing a …
Adverse reactions
M Riste, G Trafford - Clinical Medicine, 2019 - ncbi.nlm.nih.gov
Editor–I read with interest 'Lesson of the month 1: A rare adverse reaction between
flucloxacillin and paracetamol', published in March's Clinical Medicine, and write with a …
flucloxacillin and paracetamol', published in March's Clinical Medicine, and write with a …
[PDF][PDF] Néoplasie révélée par un épisode thromboembolique veineux
PPLED DE - 1992 - publication-theses.unistra.fr
Néoplasie révélée par un épisode thromboembolique veineux Page 1 1 UNIVERSITE DE
STRASBOURG FACULTE DE MEDECINE DE STRASBOURG ANNEE: 2019 N : 146 …
STRASBOURG FACULTE DE MEDECINE DE STRASBOURG ANNEE: 2019 N : 146 …
[引用][C] Cancer risk after a venous thrombotic event-RIETE score
JC Mendonça, J Martins, C Fernandes… - Thrombosis …, 2021 - thrombosisresearch.com
Unprovoked venous thromboembolism (VTE), may be the first sign of an occult cancer as 5–
10% of these patients will have a cancer diagnosis in the first year following a VTE [1, 2] …
10% of these patients will have a cancer diagnosis in the first year following a VTE [1, 2] …